Magnetic resonance imaging of iron oxide labelled stem cells: applications to tissue engineering based regeneration of the intervertebral disc.
Minimally-invasive monitoring of regeneration in diseased tissue is an important aspect of stem cell therapy. Magnetic resonance imaging (MRI) based tracking of cells labelled with ferumoxides has the potential for non-invasive in vivo detection and longitudinal assessment of implanted cells. Cells labelled with ferumoxides appear as hypointense regions on MR images and thus can be distinguished from the surroundings. Application of this methodology to intervertebral disc degeneration (IVD), and detection of labelled cells implanted into the disc for tissue regeneration was examined. Mesenchymal stem cells labelled with a ferumoxide contrast agent were imaged in vitro to quantitatively characterize the signal intensity loss using MRI relaxation parameters (T1, T2, and T2*). To determine whether labelled cells could be detected within scaffolds suitable for implantation, labelled cells were seeded within both natural and synthetic polymers and imaged using MRI. Labelled cells were loaded within poly(ethylene glycol) hydrogels and imaged in vitro using both MRI and confocal microscopy. Labelled cells were also loaded into fibrin gels, and detected ex vivo within rat IVDs using MRI. Lastly, the effect of ferumoxide labelling on cell viability was investigated. Quantitatively, labelled cells demonstrate the greatest signal intensity loss and contrast on T2*-weighted images. Labelled cells can be detected in both synthetic and natural polymers, and can be distinguished from the native tissue environment of the rat IVD. Finally, labelling does not significantly impair cell viability. Consequently, this technique shows promise as a potential method for in vivo longitudinal tracking of stem cell based regeneration of the IVD.
Saldanha
K J
KJ
MQIR, Department of Radiology, University of California, San Francisco, CA, USA. kjs@berkeley.edu
Piper
S L
SL
Ainslie
K M
KM
Kim
H T
HT
Majumdar
S
S
D000328:Adult; D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D003287:Contrast Media / Q000032:analysis / Q000378:metabolism; D003911:Dextrans; D052203:Ferrosoferric Oxide; D005337:Fibrin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D020100:Hydrogels / Q000494:pharmacology / Q000627:therapeutic use; D007403:Intervertebral Disc / Q000166:cytology / Q000502:physiology*; D007405:Intervertebral Disc Displacement / Q000628:therapy*; D007501:Iron / Q000032:analysis / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000378:metabolism*; D010087:Oxides / Q000032:analysis / Q000378:metabolism; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D012038:Regeneration / Q000502:physiology; D013194:Staining and Labeling / Q000379:methods; D033581:Stem Cell Transplantation / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods*
D003287:Contrast Media; D003911:Dextrans; D020100:Hydrogels; D058185:Magnetite Nanoparticles; D010087:Oxides; D011092:Polyethylene Glycols; D005337:Fibrin; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide